L-364,373 (R-L3) enantiomers have opposite modulating effects on Iks in mammalian ventricular myocytes

Claudia Corici, Zsófia Kohajda, Attila Kristóf, András Horváth, L. Virág, Tamás Szél, N. Nagy, Z. Szakonyi, F. Fülöp, Danina M. Muntean, A. Varró, N. Jost

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Activators of the slow delayed rectifier K+ current (IKs) have been suggested as promising tools for suppressing ventricular arrhythmias due to prolongation of repolarization. Recently, L-364,373 (R-L3) was nominated to activate IKs in myocytes from several species; however, in some studies, it failed to activate IKs. One later study suggested opposite modulating effects from the R-L3 enantiomers as a possible explanation for this discrepancy. Therefore, we analyzed the effect of the RL-3 enantiomers on IKs in ventricular mammalian myocytes, by applying standard microelectrode and whole-cell patch-clamp techniques at 37 °C. We synthesized 2 substances, ZS_1270B (right) and ZS_1271B (left), the 2 enantiomers of R-L3. In rabbit myocytes, ZS_1270B enhanced the IKs tail current by approximately 30%, whereas ZS_1271B reduced IKs tails by 45%. In guinea pig right ventricular preparations, ZS_1270B shortened APD90 (action potential duration measured at 90% repolarization) by 12%, whereas ZS_1271B lengthened it by approximately 15%. We concluded that R-L3 enantiomers in the same concentration range indeed have opposite modulating effects on IKs, which may explain why the racemic drug R-L3 previously failed to activate IKs. ZS_1270B is a potent IKs activator, therefore, this substance is appropriate to test whether IKs activators are ideal tools to suppress ventricular arrhythmias originating from prolongation of action potentials.

Original languageEnglish
Pages (from-to)586-592
Number of pages7
JournalCanadian Journal of Physiology and Pharmacology
Volume91
Issue number8
DOIs
Publication statusPublished - 2013

Fingerprint

L 364373
Muscle Cells
Action Potentials
Tail
Cardiac Arrhythmias
Microelectrodes
Patch-Clamp Techniques
Guinea Pigs
Rabbits

Keywords

  • 373
  • Antiarrhythmic drugs
  • Enantiomers
  • I activator
  • I blocker
  • L-364
  • Slow delayed rectifier potassium current

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Pharmacology

Cite this

L-364,373 (R-L3) enantiomers have opposite modulating effects on Iks in mammalian ventricular myocytes. / Corici, Claudia; Kohajda, Zsófia; Kristóf, Attila; Horváth, András; Virág, L.; Szél, Tamás; Nagy, N.; Szakonyi, Z.; Fülöp, F.; Muntean, Danina M.; Varró, A.; Jost, N.

In: Canadian Journal of Physiology and Pharmacology, Vol. 91, No. 8, 2013, p. 586-592.

Research output: Contribution to journalArticle

Corici, Claudia ; Kohajda, Zsófia ; Kristóf, Attila ; Horváth, András ; Virág, L. ; Szél, Tamás ; Nagy, N. ; Szakonyi, Z. ; Fülöp, F. ; Muntean, Danina M. ; Varró, A. ; Jost, N. / L-364,373 (R-L3) enantiomers have opposite modulating effects on Iks in mammalian ventricular myocytes. In: Canadian Journal of Physiology and Pharmacology. 2013 ; Vol. 91, No. 8. pp. 586-592.
@article{3acbdc548b064428a833e7f9a2b548ac,
title = "L-364,373 (R-L3) enantiomers have opposite modulating effects on Iks in mammalian ventricular myocytes",
abstract = "Activators of the slow delayed rectifier K+ current (IKs) have been suggested as promising tools for suppressing ventricular arrhythmias due to prolongation of repolarization. Recently, L-364,373 (R-L3) was nominated to activate IKs in myocytes from several species; however, in some studies, it failed to activate IKs. One later study suggested opposite modulating effects from the R-L3 enantiomers as a possible explanation for this discrepancy. Therefore, we analyzed the effect of the RL-3 enantiomers on IKs in ventricular mammalian myocytes, by applying standard microelectrode and whole-cell patch-clamp techniques at 37 °C. We synthesized 2 substances, ZS_1270B (right) and ZS_1271B (left), the 2 enantiomers of R-L3. In rabbit myocytes, ZS_1270B enhanced the IKs tail current by approximately 30{\%}, whereas ZS_1271B reduced IKs tails by 45{\%}. In guinea pig right ventricular preparations, ZS_1270B shortened APD90 (action potential duration measured at 90{\%} repolarization) by 12{\%}, whereas ZS_1271B lengthened it by approximately 15{\%}. We concluded that R-L3 enantiomers in the same concentration range indeed have opposite modulating effects on IKs, which may explain why the racemic drug R-L3 previously failed to activate IKs. ZS_1270B is a potent IKs activator, therefore, this substance is appropriate to test whether IKs activators are ideal tools to suppress ventricular arrhythmias originating from prolongation of action potentials.",
keywords = "373, Antiarrhythmic drugs, Enantiomers, I activator, I blocker, L-364, Slow delayed rectifier potassium current",
author = "Claudia Corici and Zs{\'o}fia Kohajda and Attila Krist{\'o}f and Andr{\'a}s Horv{\'a}th and L. Vir{\'a}g and Tam{\'a}s Sz{\'e}l and N. Nagy and Z. Szakonyi and F. F{\"u}l{\"o}p and Muntean, {Danina M.} and A. Varr{\'o} and N. Jost",
year = "2013",
doi = "10.1139/cjpp-2012-0407",
language = "English",
volume = "91",
pages = "586--592",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "8",

}

TY - JOUR

T1 - L-364,373 (R-L3) enantiomers have opposite modulating effects on Iks in mammalian ventricular myocytes

AU - Corici, Claudia

AU - Kohajda, Zsófia

AU - Kristóf, Attila

AU - Horváth, András

AU - Virág, L.

AU - Szél, Tamás

AU - Nagy, N.

AU - Szakonyi, Z.

AU - Fülöp, F.

AU - Muntean, Danina M.

AU - Varró, A.

AU - Jost, N.

PY - 2013

Y1 - 2013

N2 - Activators of the slow delayed rectifier K+ current (IKs) have been suggested as promising tools for suppressing ventricular arrhythmias due to prolongation of repolarization. Recently, L-364,373 (R-L3) was nominated to activate IKs in myocytes from several species; however, in some studies, it failed to activate IKs. One later study suggested opposite modulating effects from the R-L3 enantiomers as a possible explanation for this discrepancy. Therefore, we analyzed the effect of the RL-3 enantiomers on IKs in ventricular mammalian myocytes, by applying standard microelectrode and whole-cell patch-clamp techniques at 37 °C. We synthesized 2 substances, ZS_1270B (right) and ZS_1271B (left), the 2 enantiomers of R-L3. In rabbit myocytes, ZS_1270B enhanced the IKs tail current by approximately 30%, whereas ZS_1271B reduced IKs tails by 45%. In guinea pig right ventricular preparations, ZS_1270B shortened APD90 (action potential duration measured at 90% repolarization) by 12%, whereas ZS_1271B lengthened it by approximately 15%. We concluded that R-L3 enantiomers in the same concentration range indeed have opposite modulating effects on IKs, which may explain why the racemic drug R-L3 previously failed to activate IKs. ZS_1270B is a potent IKs activator, therefore, this substance is appropriate to test whether IKs activators are ideal tools to suppress ventricular arrhythmias originating from prolongation of action potentials.

AB - Activators of the slow delayed rectifier K+ current (IKs) have been suggested as promising tools for suppressing ventricular arrhythmias due to prolongation of repolarization. Recently, L-364,373 (R-L3) was nominated to activate IKs in myocytes from several species; however, in some studies, it failed to activate IKs. One later study suggested opposite modulating effects from the R-L3 enantiomers as a possible explanation for this discrepancy. Therefore, we analyzed the effect of the RL-3 enantiomers on IKs in ventricular mammalian myocytes, by applying standard microelectrode and whole-cell patch-clamp techniques at 37 °C. We synthesized 2 substances, ZS_1270B (right) and ZS_1271B (left), the 2 enantiomers of R-L3. In rabbit myocytes, ZS_1270B enhanced the IKs tail current by approximately 30%, whereas ZS_1271B reduced IKs tails by 45%. In guinea pig right ventricular preparations, ZS_1270B shortened APD90 (action potential duration measured at 90% repolarization) by 12%, whereas ZS_1271B lengthened it by approximately 15%. We concluded that R-L3 enantiomers in the same concentration range indeed have opposite modulating effects on IKs, which may explain why the racemic drug R-L3 previously failed to activate IKs. ZS_1270B is a potent IKs activator, therefore, this substance is appropriate to test whether IKs activators are ideal tools to suppress ventricular arrhythmias originating from prolongation of action potentials.

KW - 373

KW - Antiarrhythmic drugs

KW - Enantiomers

KW - I activator

KW - I blocker

KW - L-364

KW - Slow delayed rectifier potassium current

UR - http://www.scopus.com/inward/record.url?scp=84880742751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880742751&partnerID=8YFLogxK

U2 - 10.1139/cjpp-2012-0407

DO - 10.1139/cjpp-2012-0407

M3 - Article

VL - 91

SP - 586

EP - 592

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 8

ER -